Health Technology Assessment of In Vitro Diagnostic Tests

Original Language Version (Spanish and English): 

Spanish version:

English version: 

The Pan American Health Organization and the Health Technology Assessment Network of the Americas (RedETSA), in conjunction with Health Technology Assessment International (HTAi), organized a new webinar entitled: “Health Technology Assessment of In Vitro Diagnostic Tests”.

Date: Friday, May 23, 2025

Speakers

– Christopher Hyde, University of Exeter, United Kingdom

– Federico Augustovski, IECS, Argentina 

– Rosa Maria Vivanco Hidalgo, AQuaS, Spain

– Virgilio Failoc Rojas, INEN, Peru

Moderators

– Anastasia Chalkidou, NICE, UK & Co-Chair of the HTAi Medical Devices Interest Group

– Stephanie Ouimet-Rathe, PAHO, Innovation, Access to Medicines and Health Technologies (IMT)

Context

Health Technology Assessment (HTA) aims to inform decision-making to promote equitable, efficient, and high-quality health systems. The evaluation of in vitro diagnostic tests plays a crucial role in public health, and access to this type of technology is essential to ensure accurate diagnoses, appropriate treatments, and continuous monitoring of patient health.

About the Webinar

The webinar addressed current Health Technology Assessment methods for diagnostics, challenges in applying these methods to in vitro diagnostics, perspectives from international organizations, the presentation of a value framework for diagnostic technologies in Latin America, and case studies from HTA agencies evaluating in vitro diagnostic tests.